Benicar and Mevacor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benicar (olmesartan medoxomil) and Mevacor (lovastatin). Common drug interactions include memory impairment among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Benicar and Mevacor. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is Mevacor?

Mevacor has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 4,988 Mevacor users. Check the latest studies of Mevacor.

On Jul, 20, 2026

34 people who take Benicar and Mevacor together, and have interactions are studied.

What are the common drug interactions of Benicar and Mevacor, by gender? *:

female:

Memory impairment
Mesenteric arteriosclerosis (hardening of mesenteric artery)
Mitral valve incompetence (inefficient heart valve)
Nephrosclerosis (hardening of the kidney due to renovascular disease)
Obesity (having too much body fat)
Pain in extremity
Pancreatic leak
Pancreatitis (inflammation of pancreas)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pelvic fluid collection

male:

Chronic kidney disease
Renal injury (kidney injury)
Speech disorder
Chest pain
Confusional state
Dizziness
Drug ineffective
Fall
Headache (pain in head)
Myalgia (muscle pain)

What are the common drug interactions of Benicar and Mevacor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Mesenteric arteriosclerosis (hardening of mesenteric artery)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephrosclerosis (hardening of the kidney due to renovascular disease)
Pancreatic leak
Pancreatitis (inflammation of pancreas)
Pelvic fluid collection
Peripancreatic fluid collection
Pleural effusion (water on the lungs)
Renal artery arteriosclerosis (a thickening and hardening of renal artery)

60+:

Chronic kidney disease
Renal injury (kidney injury)
Blood urea increased
Drug ineffective
Dry mouth
Joint swelling
Lipids decreased (less lipid in body)
Oedema peripheral (superficial swelling)
Abdominal distension
Anaphylactic reaction (serious allergic reaction)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 23.53%
Pain: 7 people, 20.59%
Gout (uric acid crystals building up in the body): 7 people, 20.59%
Gastric Ulcer (stomach ulcer): 7 people, 20.59%
Renal Disorder (kidney disease): 6 people, 17.65%
Anaemia (lack of blood): 6 people, 17.65%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 3 people, 8.82%
Osteoporosis (bones weak and more likely to break): 3 people, 8.82%
Neuropathy Peripheral (surface nerve damage): 3 people, 8.82%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar and Mevacor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously